Business Daily Media

Men's Weekly

.

Meet the CEO who is taking the global stage to reform clinical trials

Clinical trials are the lifeline of the healthcare industry, propelling the development of innovative treatments and therapies for a wide spectrum of medical conditions. Surprisingly, many individuals remain unaware of the significance and breadth of clinical trials, often mistakenly associating them exclusively with vaccines and oncology. However, the reality is that clinical trials encompass a diverse range of medical interventions, including drugs, devices, and behavioural therapies, playing a pivotal role in advancing healthcare.

Charlotte Bradshaw, the CEO of Evrima Technologies, a pioneering Australian firm specialising in clinical trial recruitment solutions, aims to change public perception. Drawing a parallel between participating in clinical trials and donating blood, she emphasises their crucial role in advancing medical knowledge and improving healthcare outcomes for individuals and communities. "Without research participants, we would not have the opportunity to bring new therapies to market. It is equally important to raise awareness of clinical trials as a care option, empowering both patients and clinicians through technology," Charlotte explains.

Since February 2021, Evrima Technologies has experienced exponential growth, expanding its products and services. The achievements of the company in a short span of time are noteworthy:

  • Team Expansion: The company has witnessed a remarkable 43.5% growth in its workforce, reflecting the increasing demand for its services.

  • Successful Partnerships: Evrima Technologies has secured contracts with leading bio-pharmaceutical clients, many of whom have become repeat customers, highlighting the value they find in the company's offerings.

  • Recognition and Awards: The company's exceptional performance has been acknowledged by prestigious organisations. It ranked #29 in the AFR Fast 100 Starters for 2022 and received the Female Leadership Award at Deloitte's Tech Fast 50 Australia 2021. Additionally, it secured the Rising Star Award, further highlighting its remarkable progress.

According to Charlotte Bradshaw, the future of clinical trials in Australia looks promising, largely due to the integration of technology. Notably, technology has played a crucial role in connecting clinical trials to individuals residing in rural and remote areas. Furthermore, the company's ability to translate clinical trial documentation into multiple languages has broken down language barriers, benefiting participants with English as a second language. This inclusivity fosters greater diversity and ensures that a wider range of individuals can contribute to medical research.

Bradshaw also points to the impact of the COVID-19 pandemic, which has demonstrated the potential of remote communication and online services. Just as online shopping and home deliveries have transformed our daily lives, the same convenience can be extended to clinical trials. Participants would no longer be required to attend in-person visits on a regular basis, enabling them to contribute to research from the comfort of their own homes. This innovative approach not only enhances convenience but also addresses the longstanding challenge of lengthy trial durations. On average, it takes a decade or more for new treatments to reach the market. By leveraging cutting-edge technology, Evrima Technologies aims to reduce the administrative burden on researchers, allowing them to focus on the critical clinical work necessary to expedite the journey from laboratory to patient care.

The integration of technology into clinical trials represents a monumental leap forward for the healthcare industry. Evrima Technologies, under the visionary leadership of Charlotte Bradshaw, has embraced this opportunity to revolutionise the recruitment process, bringing trials to the fingertips of individuals who can contribute to medical advancements. By creating awareness, breaking down barriers, and streamlining the research process, technology is paving the way for faster and more efficient development of life-changing treatments and therapies. As we look to the future, it is crucial that we continue to support and foster the growth of innovative solutions that empower both patients and researchers, ultimately transforming the landscape of healthcare for the better.

For more information about Evrima Technologies, please visit www.evrima.com.

Minns Labor Government shutting down the Business Connect program

The NSW Opposition is concerned that the Labor government will shut down a support program that has assisted New South Wales businesses. In a media ...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...

Why it’s time telcos rethink location and put customer experience first

Maurice Zicman, Vice President - CX Strategy at TP in Australia unpacks why the telco industry must rethink old assumptions and focus on digital-f...